Esophageal strictures are the most common complications of bullous epidermolysis in children. Strictures cause the development of dysphagia that prevents oral alimentation and receipt of an adequate amount of nutrients that is accompanied by a violation of nutritional status, weight loss, and delayed physical development of a child. Disturbed swallowing can also cause aspiration syndrome, pneumonia, and airway obstruction. To eliminate dysphagia and reduce the risk of complications, it is necessary to restore esophageal patency. The article describes the results of X-ray with assisted balloon dilatation in 19 children with bullous epidermolysis and dysphagia. It is shown that this method of esophagus recanalization allows to effectively and safely restore oral alimentation of children already in the first day after intervention with a gradual expansion of the diet.
Of the Ministry of Health of the Russian FederationEsophageal stricture in children with epidermolysis bullosa is one of the most frequent complications which cause dysphagia symptoms and severe malnutrition.Aimto prove efficiency and safety of balloon dilatation in esophageal stricture’s treatment in children with epidermolysis bullosa.Methodsretrospectively we reviewed the charts of 19 patients with epidermolysis bullosa aged 4–17 years who had dysphagia symptoms and esophageal stricture, confirmed on contrast x-ray examination of the upper gastrointestinal tract. All patients were undergone fluoroscopically guided balloon dilatation of esophageal stricture. The first endpoint was a technical success of the procedure, esophageal lumen retrieve and relief dysphagia symptoms. The second endpoin was reintervention rate. Statistical analysis was conducted in Statistica 7.0 (USA). To assess statistical significance were used student’s t-test. Reliable considered differences with a probability of at least 95% (p<0.05).Results19 patients with recessive dystrophic epidermolisis bullosa, dysphagia and esophageal stricture which was radiology verified, were treated with fluoroscopically guided balloon dilatation. The technical success rate was 100%. The mean follow-up time was 8.45±4,02 months (range, 4–19). The major part of the strictures was situated in the upper (10/21 [47.6%]) and middle (10/21 [47.6%]) esophageal segment, 1 stricture was in lower esophageal segment. Almost all of them were short focal strictures (less than 3 cm) III-IV grade [mean diameter 2,8 mm]by the Gallinger Yu.L., Godzhello E.A. endoscopic classification. One patient had a multiple strictures (1 in the upper esophageal segment, 1 in the middle esophageal segment) and one patient with inverse form of epidermolisis bullosa had a long stricture (more than 5 cm) which required 2 balloon dilatations during 1 procedure. After 12 months in patient with inverse form of epidermolisis bullosa stricture with symptoms of dysphagia relapsed and was successfully treated by reintervention. The stricture had the same characteristics as a previous case. Relapses in other cases were not occur and reintervention rate was 5,2% (1/19). Balloon diameter ranged from 8 to 18 mm. The postprocedural dysphagia score (0,32 [95% CI,0,09–0,55]) was significantly lower than baseline (2.95 [95% CI, 2,59–3,31]) (p<0,0001). Full expansion of the stricture’s“waist” was achieved in all cases. No procedural-related complications were detected. In 16% (3/19) of cases showed rise in body temperature on the day of surgery to febrile values which were cropped by NSAIDs. Almost all patients within 3–4 days had a slight pain and discomfort when swallowing, but it was not an obstacle for adequate oral feeding and gradual increase in enteral feeding with the expansion of the diet.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.